Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

The guidelines for classification, prognostication, and response assessment of myelodysplastic syndromes/neoplasms (MDS) have all recently been updated. In this report on behalf of the International Consortium for MDS (icMDS) we summarize these developments. We first critically examine the updated W...

書誌詳細
主要な著者:	Stahl, M, Bewersdorf, JP, Xie, Z, Porta, MGD, Komrokji, R, Xu, ML, Abdel-Wahab, O, Taylor, J, Steensma, DP, Starczynowski, DT, Sekeres, MA, Sanz, G, Sallman, DA, Roboz, GJ, Platzbecker, U, Patnaik, MM, Padron, E, Odenike, O, Nimer, SD, Nazha, A, Majeti, R, Loghavi, S, Little, RF, List, AF, Kim, TK, Hourigan, CS, Hasserjian, RP, Halene, S, Griffiths, EA, Gore, SD, Greenberg, P, Figueroa, ME, Fenaux, P, Efficace, F, DeZern, AE, Daver, NG, Churpek, JE, Carraway, HE, Buckstein, R, Brunner, AM, Boultwood, J, Borate, U, Bejar, R, Bennett, JM, Wei, AH, Santini, V, Savona, MR, Zeidan, AM
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2023

類似資料

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
著者:: Efficace, F, 等
出版事項: (2024)

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
著者:: Fabio Efficace, 等
出版事項: (2024-05-01)

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM WHO 2017 TO WHO 2022 AND ICC 2022): AN EXPANDED ANALYSIS OF 7017 PATIENTS ON BEHALF OF THE INTERNATIONAL CONSORTIUM FOR MDS (ICMDS)
著者:: Rami S. Komrokji, 等
出版事項: (2023-08-01)

Generalized GM-MDS: Polynomial Codes Are Higher Order MDS
著者:: Brakensiek, Joshua, 等
出版事項: (2024)

The weights in MDS codes
著者:: Ezerman, Martianus Frederic, 等
出版事項: (2019)

Construction of MDS matrices
著者:: Peng-fei LI, 等
出版事項: (2016-06-01)

Application of classical Hermitian self-orthogonal MDS codes to quantum MDS codes
著者:: Jin, Lingfei, 等
出版事項: (2012)

PB1999: TOBACCO SMOKING IN MDS PATIENTS – ANALYSIS FROM THE MDS PALG REGISTRY
著者:: Rafal Machowicz, 等
出版事項: (2023-08-01)

THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (t-MDS) IN CHILDHOOD: THE EXPERIENCE OF THE HELLENIC STUDY GROUP FOR MDS/JMML/SAA, MEMBER OF THE EWOG-MDS/SAA WORKING GROUP
著者:: Loizos Petrikkos, 等
出版事項: (2023-12-01)

New quantum MDS codes
著者:: Zhang, Guanghui, 等
出版事項: (2015)

Inherited predisposition to MDS/AML
著者:: Ana Rio Machin, 等
出版事項: (2018-06-01)

The impact of spliceosome mutations in MDS
著者:: Jacqueline Boultwood, 等
出版事項: (2019-06-01)

MDS-482 Impact of magrolimab in combination with azacitidine on red blood cells (RBCs) in patients with higher-risk myelodysplastic syndromes (HR MDS)
著者:: Chen, J, 等
出版事項: (2022)

P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY
著者:: F. Schulz, 等
出版事項: (2022-06-01)

MDS plus data acquisition system
著者:: Stillerman, J.A., 等
出版事項: (2015)

Diffusion analysis of EFN-MDS structure
著者:: Ibrahim, Subariah
出版事項: (2006)

Diffusion analysis of EFN-MDS structure
著者:: Ibrahim, Subariah, 等
出版事項: (2006)

The role of innate immunity in MDS pathogenesis
著者:: David A. Sallman, 等
出版事項: (2019-06-01)

High-risk MDS after HMAs
著者:: Lionel Adès
出版事項: (2019-06-01)

P743: THE PIVOTAL ROLE OF GLUTAMINOLYSIS IN MYELODYSPLASTIC SYNDROME (MDS): A NOVEL STRATEGY FOR THE TARGETED THERAPY OF MDS
著者:: S. Okabe, 等
出版事項: (2022-06-01)

IMPLICATIONS OF NOVEL CLASSIFICATIONS OF MYELOID NEOPLASMS FOR CHILDHOOD MDS
著者:: Katherine R. Calvo
出版事項: (2023-12-01)

DHPLC analysis of the ATRX gene in myelodysplastic syndrome (MDS) associated with acquired alpha thalassemia (AT-MDS): Novel mutation detection despite somatic mosaicism.
著者:: Steensma, D, 等
出版事項: (2003)

Integrated genetic, epigenetic, and immune landscape of mutant AML and higher risk MDS treated with azacitidine
著者:: Amer M. Zeidan, 等
出版事項: (2024-06-01)

Application of constacyclic codes to quantum MDS codes
著者:: Chen, Bocong, 等
出版事項: (2015)

A construction of MDS quantum convolutional codes
著者:: Zhang, Guanghui, 等
出版事項: (2015)

Trisomy X and myelodysplastic syndrome (MDS) with eosinophilia
著者:: Mohd Tohit, Eusni Rahayu, 等
出版事項: (2012)

On linear codes whose hermitian hulls are MDS
著者:: Luo, Gaojun, 等
出版事項: (2024)

HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
著者:: Mazyar Shadman, 等
出版事項: (2014-09-01)

Value-based adoption of MDS:an empirical investigation
著者:: ZHOU Yi1, 等
出版事項: (2008-01-01)

Editorial: MDS: new scientific and clinical developments
著者:: Sabine Blum, 等
出版事項: (2025-02-01)

Value-based adoption of MDS:an empirical investigation
著者:: ZHOU Yi1, 等
出版事項: (2008-01-01)

Understanding iron homeostasis in MDS: the role of erythroferrone
著者:: Mohammed L. Abba, 等
出版事項: (2024-05-01)

Controversies on the Consequences of Iron Overload and Chelation in MDS
著者:: Francesca Vinchi, 等
出版事項: (2020-06-01)

Recent advances in MDS mutation landscape: splicing and signalling
著者:: Follo, MY, 等
出版事項: (2019)

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
著者:: Theo de Witte, 等
出版事項: (2020-09-01)

P703: THE AIPSS-MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS
著者:: Adrian Mosquera-Orgueira, 等
出版事項: (2023-08-01)

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
著者:: Malcovati, L, 等
出版事項: (2020)

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1)
著者:: A. DeZern, 等
出版事項: (2022-06-01)

New Systematic MDS Array Codes With Two Parities
著者:: Lan Ma, 等
出版事項: (2024-01-01)

MDS CODEC EVALUATION BASED ON PERCEPTUAL SOUND ATTRIBUTES
著者:: Marcelo Herrera Martínez, 等
出版事項: (2014-12-01)